Novo Offers Wegovy at $199 for First Month as Copycats End (1)

May 22, 2025, 1:33 PM UTC

Novo Nordisk A/S is selling its blockbuster weight-loss drug Wegovy to new patients at $199 for the first month as easy access to cheaper copycats comes to an end.

The one-time offer — available through June 30 — is intended for patients who were taking copycat, or compounded, versions of Wegovy. After that, it will cost $499 a month for self-paying customers.

On Thursday, pharmacies were supposed to stop making the copies of the medications that had become popular during shortages of the brand-name drugs.

“We are doubling down on our commitment to accessibility, availability, and affordability of authentic, FDA-approved ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.